Progression Free Survival (IMAGE) Bentham Science Publishers Caption This graph shows progression free survival from hormone therapy in 42 endocrine-dependent metastatic breast cancer patients (by the Kaplan-Meier method); median survival time and 95 percent CI: 33, 24.4-41.6 months. Credit Dr. Andrea Nicolini et al., Bentham Science Publishers Usage Restrictions Image rights belong to Dr. Andrea Nicolini et al., Bentham Science Publishers License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.